Lazard Asset Management Portfolio holdings

Lazard Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.

• Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
• Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
• Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
• Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
• Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
• Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
• Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.

Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.